What Should Be Done When Symptoms Persist but IBD Appears to Be in Remission?

Answer in brief: Do not automatically escalate IBD therapy when symptoms persist in apparent remission. First verify whether inflammation is truly controlled with objective testing. If it is, investigate non-inflammatory causes such as IBS overlap, bile-acid diarrhea, SIBO, pancreatic insufficiency, lactose/FODMAP intolerance, pelvic-floor dysfunction, medication effects, strictures or postsurgical anatomy.

“Remission” should be objectively credible

Symptoms and inflammation correlate imperfectly. A patient may have occult disease despite mild symptoms, or substantial symptoms despite mucosal healing. Fecal calprotectin, CRP, endoscopy and/or imaging are chosen according to disease location and the clinical question.

IBS overlap is common

Abdominal pain, bloating and altered stool form may persist after inflammatory control. Once active IBD has been reasonably excluded, a disorder of gut-brain interaction should be considered rather than repeatedly intensifying immunosuppression.

Look for disease consequences, not just disease activity

Crohn’s strictures can cause obstructive symptoms despite low inflammatory biomarkers. Ileal disease or resection can produce bile-acid diarrhea. Prior surgery changes transit and anatomy. Small-bowel bacterial overgrowth, pancreatic insufficiency and pelvic-floor disorders are additional possibilities.

Medication and diet can contribute

Metformin, magnesium, antibiotics and other drugs may cause diarrhea. Restrictive diets may create nutritional problems without addressing the true mechanism. Dietary intervention should be targeted and ideally supported by an IBD-informed dietitian.

Treat the identified mechanism

Management may include bile-acid sequestrants, constipation therapy, pelvic-floor treatment, dietary modification, neuromodulators or other IBS-directed care. The key is that these therapies are added because inflammation is controlled—not as a substitute for treating active IBD.

What trainees should remember

Persistent symptoms are a diagnostic problem, not automatic evidence of treatment failure. Reconfirm inflammatory control, then identify the non-inflammatory mechanism before changing immunosuppression.

Frequently asked questions

Can a patient with endoscopic remission still have severe symptoms?

Yes. Functional symptoms and structural consequences of prior disease can be clinically significant despite mucosal healing.

Should fecal calprotectin be normal in every patient in remission?

Not always, and interpretation depends on disease location and context. It is one component of objective assessment, not an infallible test.

References and further reading

1. Thomson ABR. Practice Review in Gastroenterology. CAPstone Academic Publishers; 2014.

2. Thomson ABR. First Principles of Gastroenterology and Hepatology in Adults and Children, 7th ed. CAPstone Academic Publishers; 2013.

3. Lichtenstein GR, et al. ACG Clinical Guideline: Management of Crohn's Disease in Adults. Am J Gastroenterol. 2025.